Drug Screening

The FCG works with investigators to perform all necessary assay optimization and validation. The FCG staff then translates the protocol into a high throughput workflow on our liquid handling workstation and works with the researchers to perform their compound screen. The primary limit on the throughput of the screen is the speed of the assay. Simple fluorescence based assays can be read on our BioTek Synergy 2, while complex cell phenotyping on the Cellomics ArrayScan VTI can take over an hour per plate.

 

Do you have a novel Drug Target? (link is external)

Contact
Warren Hoe (link sends e-mail)
Business Development Associate
BIO5 Institute
The University of Arizona
520.626.9750
www.bio5orovalley.org

Related  Services: